Preeclampsia-induced alterations in brain and liver gene expression and DNA methylation patterns in fetal mice

J Dev Orig Health Dis. 2023 Feb;14(1):146-151. doi: 10.1017/S2040174422000344. Epub 2022 Jun 24.

Abstract

Exposure to pregnancy complications, including preeclampsia (PE), has lifelong influences on offspring's health. We have previously reported that experimental PE, induced in mice by administration of adenoviral sFlt1 at gestational day 8.5 combined with LPS at day 10.5, results in symmetrical growth restriction in female and asymmetrical growth restriction in male offspring. Here, we characterize the molecular phenotype of the fetal brain and liver with respect to gene transcription and DNA methylation at the end of gestation.In fetal brain and liver, expression and DNA methylation of several key regulatory genes is altered by PE exposure, mostly independent of fetal sex. These alterations point toward a decreased gluconeogenesis in the liver and stimulated neurogenesis in the brain, potentially affecting long-term brain and liver function. The observed sex-specific growth restriction pattern is not reflected in the molecular data, showing that PE, rather than tissue growth, drives the molecular phenotype of PE-exposed offspring.

Keywords: Brain sparing; fetal growth restriction; fetal programming; metabolism; neurodevelopment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism
  • DNA Methylation*
  • Female
  • Gene Expression
  • Humans
  • Liver / metabolism
  • Male
  • Mice
  • Pre-Eclampsia* / genetics
  • Pregnancy
  • Vascular Endothelial Growth Factor Receptor-1

Substances

  • Vascular Endothelial Growth Factor Receptor-1